NEW YORK, Nov. 20, 2022 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA)’s merger with Advaxis, Inc. Upon completion of the merger, Ayala stockholders would own approximately 62.5% of the combined company’s outstanding common stock. If you are an Ayala shareholder, click here to learn more about your rights and options.
Myovant Sciences Ltd. (NYSE: MYOV)’s sale to Sumitovant Biopharma Ltd. for $27.00 per share in cash. If you are a Myovant shareholder, click here to learn more about your rights and options.
UserTesting, Inc. (NYSE: USER)’s sale to Thoma Bravo for $7.50 per share. If you are a UserTesting shareholder, click here to learn more about your rights and options.
AgroFresh Solutions, Inc. (NASDAQ: AGFS)’s proposed sale to Paine Schwartz Partners for $3.00 per share in cash. If you are an AgroFresh shareholder, click here to learn more about your rights and options.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email email@example.com or firstname.lastname@example.org.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
- Paycor Announces Upsize and Pricing of Offering of Common Stock by Selling Stockholders - December 2, 2022
- springbig Honored at 2022 South Florida Business Journal Miami Inno Fire Awards - December 2, 2022
- Anti-Static Films Market Size to Surpass USD 767.66 Million by 2030 at 4.57% CAGR – Report by Market Research Future (MRFR) - December 2, 2022